- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
4 result(s) found for: Flumazenil.
Displaying page 1 of 1.
EudraCT Number: 2014-000420-15 | Sponsor Protocol Number: AKF1919 | Start Date*: 2016-03-24 | |||||||||||
Sponsor Name:Radboud University Medical Centre, department of Psychiatry | |||||||||||||
Full Title: Slow continuous subcutaneous flumazenil infusion for benzodiazepine dependence: a pilot study | |||||||||||||
Medical condition: Patients diagnosed with benzodiazepine dependence with an average daily dose of at least 30 mg of diazepam equivalence. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003287-18 | Sponsor Protocol Number: PET-FRAX-001 | Start Date*: 2008-09-17 |
Sponsor Name:University Antwerp [...] | ||
Full Title: Functional consequences of decreased RNA expression of certain GABA(A) receptor subunits in fragile X patients using Positron Emission Tomography and [11C]flumazenil. | ||
Medical condition: Fragile X syndrome is the most common form of inherited mental retardation with a prevalence of 1/4000 males and 1/6000 females. Patients are characterized by a mild to severe form of cognitive imp... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002636-16 | Sponsor Protocol Number: VUMC-ANW-MS-GG-062017 | Start Date*: 2017-10-09 |
Sponsor Name:VU University medical center Amsterdam | ||
Full Title: Cognitive impairment and functional reorganization in multiple sclerosis: The role of GABA and glutamate | ||
Medical condition: Multiple Sclerosis (MS). And specifically cognitive problems in MS. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004118-37 | Sponsor Protocol Number: CNS7056-026 | Start Date*: 2021-08-31 | |||||||||||
Sponsor Name:PAION UK Ltd [...] | |||||||||||||
Full Title: A Phase 2/3, prospective, open-label trial evaluating the efficacy, safety, and pharmacokinetics of remimazolam for intravenous sedation in paediatric patients undergoing diagnostic and/or therapeu... | |||||||||||||
Medical condition: Paediatric procedural sedation | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
